stab at a china financial model, page-50

The last two words are intersting!




'The final stage of the agreement ensures that SiYi will continue their investment to fully localise the production of OraLine IV. At this stage, SBL will continue to
produce and sell the illicit drug testing chemistry to SiYi.

Movement to Stage 3 is volume dependant upon SiYi manufacturing a minimum 1,000,000 units of Oraline IV per annum.

In addition, SBL will supply the membrane chemistry for use in the Oraline IV manufactured by SiYi. As part of Stage 3, SiYi will seek ISO13485 certification to enable SBL to utilise the facility for OEM manufacturing of OraLine IV and other devices.'